PHARMAC announces decision to fund Trikafta

PHARMAC

7 March 2023 - Pharmac has today confirmed the funding of elexacaftor with tezacaftor and ivacaftor (Trikafta) for people with cystic fibrosis, aged 6 years and above, who meet certain eligibility criteria.

Trikafta will be listed on the Pharmaceutical Schedule from 1 April 2023, subject to eligibility criteria.

Read PHARMAC press release

Michael Wonder

Posted by:

Michael Wonder